Related content

Association of R279Q and C1562T polymorphisms of matrix metalloproteinase 9 gene and increased risk for myocardial infarction in patients with premature coronary artery disease

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs: Clinical Relevance

By Kirchheiner Julia   Roots Ivar   Goldammer Mark   Rosenkranz Bernd  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1209-1225

Adis International

Access to resources Recommend Favorite

Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment

By Gschwind Liliane   Rollason Victoria   Boehlen Françoise   Rebsamen Michela   Combescure Christophe   Grünenwald Michèle   Matthey Alain   Bonnabry Pascal   Dayer Pierre   Desmeules Jules Alexandre  

Pharmacogenomics, Vol. 14, Iss. 7, 2013-05 ,pp. : 745-753

Future Medicine

Access to resources Recommend Favorite

Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids

By Kirchheiner Julia   Meineke Ingolf   Fuhr Uwe   Rodrííguez-Antona Cristina   Lebedeva Elena   Brockmööller Jüürgen  

Pharmacogenomics, Vol. 9, Iss. 3, 2008-03 ,pp. : 277-288

Future Medicine

Access to resources Recommend Favorite

Warfarin: CYP2C9 polymorphisms increase risk of bleeding events

By  

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite